Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene
Clinical trial NCT04671433 · COMPLETED
Trial details
- NCT number
- NCT04671433
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-04
- Primary completion
- 2024-09-30
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.